Europe abandons plans for flagship billioneuro research projects

first_img The six teams were told in March, Vandenberghe says. “Everyone is aware,” he says. “Whether everyone is happy with this, of course, is something else.” Each candidate was awarded €1 million earlier this year to develop a detailed proposal and had already lined up support from hundreds of scientists at dozens of institutions and industry partners. “It’s extremely disappointing, of course. Many great researchers worked very hard to develop this,” says Paul Lukowicz of the German Research Center for Artificial Intelligence in Kaiserslautern, who coordinates a candidate project called Humane AI.In the current competition, 33 proposals were submitted in 2018 and whittled down to the six finalists, which were supposed to be announced at a meeting in Vienna in December 2018. But a week before that meeting, the commission canceled it, citing “extensive discussions” about the shape of Horizon Europe. Later, the teams were told to drop any mention of “flagships” and instead talk about “large scale research initiatives.”Although none of the projects was ever guaranteed to win the flagship funding, changing the whole system in the middle of the competition is disconcerting, says Hans-Dieter Volk, an immunologist at the Charité University Clinic here. Volk is coordinator for a third Germany-based project, called RESTORE, which aims to push gene- and cell-based therapies into European clinics faster and more cheaply. When Martin Lohse, scientific director of the Max Delbrück Center for Molecular Medicine here, welcomed participants to the kick-off meeting for a massive biomedical consortium last week, he wished them well, even though they would be spending their time in the dark. Lohse was talking about the windowless lecture hall, but he might as well have been referring to the murky future of the megaproject.The consortium, called LifeTime, aims to use three emerging technologies—machine learning, the study of single cells, and lab-grown organlike tissues called organoids—to map how human cells change over time and develop diseases. It is one of six candidates in the latest round of ambitious proposals for European flagships, billion-euro research projects intended to run for 10 years. There is just one snag: The European Commission has decided that it won’t launch any of them.Three existing flagships will continue under plans developed through Horizon 2020, the European Union’s science funding framework: projects on graphene, the human brain, and quantum technology. Details for Horizon 2020’s successor, Horizon Europe, are still being hashed out, but last month, the commission and the European Parliament agreed to a program structure, and it does not include the two or three new flagships the commission had previously intended to pick in 2020. “There was a strong sense by the community overall that we had too many different funding instruments and funding approaches,” says Kurt Vandenberghe, director for research policy at the commission’s Directorate-General for Research and Innovation in Brussels. “We have tried to streamline this.” He says the six candidates may somehow be folded into Horizon Europe, which will run from 2021 to 2027. Two other projects propose to use sunlight and atmospheric gases like carbon dioxide to produce fuels and fertilizers. One, called SUNRISE, is led by Leiden University in the Netherlands and another, called ENERGY-X, by the Technical University of Denmark in Copenhagen. The sixth proposal, Time Machine, would digitize vast troves of historical data from European archives and museums.Whether and how any of these projects might now go ahead is unclear. Christian Ehler, the European Parliament’s lead negotiator on Horizon Europe in Brussels, says he plans to urge the commission to integrate the projects into Horizon Europe. “Parliament is very worried about the future of these preselected projects,” he says. “These are promising initiatives and should be given the right long-term large-scale framework under Horizon Europe.”Vandenberghe suggests that one or several of the flagship proposals could be funded through the five so-called mission areas of Horizon Europe. New with this spending plan, the missions direct research spending toward specific challenges: cancer, climate adaptation, healthy oceans, climate neutral cities, and healthy soils. The European Union hopes the new structure will help it measure the societal impact of its research funding and communicate its importance. But the missions won’t be fully defined for several years. Even then, they might not foster the kind of centralization and integration that most of the flagship proposals are aiming for.For now, the consortia are continuing to develop detailed road maps for their proposed projects, which are due in May 2020. But some aspects of a project, like its governance, are difficult to plan when the funding source is unclear, says Geneviève Almouzni, LifeTime’s co-coordinator at the Curie Institute in Paris. Brexit, the possible departure of the United Kingdom from the European Union later this year, also complicates planning. LifeTime, for example, has included U.K. partners but not in critical positions.Nikolaus Rajewsky of the Max Delbrück Center, who is also a co-coordinator of LifeTime, says the project’s merits are clear. “It doesn’t take a genius to realize that this will probably deliver some major insights into diseases.” National governments and funding agencies have shown a lot of interest, and even German Chancellor Angela Merkel recently mentioned the project, he notes. Once the plan is fleshed out, the money will hopefully follow, he says. “I don’t really care whether you call that a flagship or a lighthouse or something else.” Fallen giants The European Commission planned to select two or three billion-euro “flagship” projects from a short list of six finalists. Now, it says it won’t.  Click to view the privacy policy. Required fields are indicated by an asterisk (*) German Chancellor Angela Merkel looks at lab-grown minibrains at the Max Delbrück Center for Molecular Medicine in Berlin. Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Europe abandons plans for ‘flagship’ billion-euro research projects David Ausserhofer/MDC Sign up for our daily newsletter Get more great content like this delivered right to you! Country By Kai KupferschmidtMay. 14, 2019 , 3:20 PM Email NameGoalLead institution NameTime MachineGoalDigitize Europe’s cultural heritage.Lead institutionFederal Institute of Technology in Lausanne, Switzerland NameHumane AIGoalDevelop artificial intelligence to work with humans.Lead institutionGerman Research Center for Artificial Intelligence in Kaiserslautern NameLifeTimeGoalMap how cells develop over time.Lead institutionMax Delbrück Center for Molecular Medicine in Berlin NameRESTOREGoalBring cell and gene therapies into the clinic.Lead institutionCharité University Clinic in Berlin NameENERGY-XGoalConvert solar and wind energy into fuels.Lead institutionTechnical University of Denmark in Copenhagen NameSUNRISEGoalUse sunlight and atmospheric gases to make fuels and chemicals.Lead institutionLeiden University in the Netherlands last_img

Leave a Reply

Your email address will not be published. Required fields are marked *